DLHAX
Price
$22.38
Change
+$0.19 (+0.86%)
Updated
Apr 17 closing price
Net Assets
641.71M
JFNIX
Price
$64.83
Change
+$0.02 (+0.03%)
Updated
Apr 17 closing price
Net Assets
4.71B
Ad is loading...

DLHAX vs JFNIX

Header iconDLHAX vs JFNIX Comparison
Open Charts DLHAX vs JFNIXBanner chart's image
Macquarie Healthcare A
Price$22.38
Change+$0.19 (+0.86%)
VolumeN/A
Net Assets641.71M
Janus Henderson Global Life Sciences I
Price$64.83
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets4.71B
DLHAX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHAX vs. JFNIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Hold and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.71B vs. DLHAX (642M). JFNIX pays higher dividends than DLHAX: JFNIX (0.39) vs DLHAX (0.10). DLHAX was incepted earlier than JFNIX: DLHAX (18 years) vs JFNIX (16 years). DLHAX (1.25) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLHAX (5.00). DLHAX has a lower initial minimum investment than JFNIX: DLHAX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -7.78 vs. DLHAX (-13.38). JFNIX return over 5 years is better than : 12.94 vs. DLHAX (-11.51).
DLHAXJFNIXDLHAX / JFNIX
Total Expense Ratio1.210.77157%
Annual Report Gross Expense Ratio1.250.77162%
Fund Existence18 years16 years-
Gain YTD-5.768-4.690123%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets642M4.71B14%
Annual Yield % from dividends0.100.3925%
Returns for 1 year-13.38-7.78172%
Returns for 3 years-18.82-0.702,701%
Returns for 5 years-11.5112.94-89%
Returns for 10 years10.329.62107%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ROFCX9.410.09
+0.97%
Royce Small-Cap Opportunity Consult
PUVCX40.43N/A
N/A
Putnam International Capital Opp C
JLCAX17.61N/A
N/A
JPMorgan US Large Cap Core Plus A
CENNX12.32N/A
N/A
Centerstone Investors C
RNGFX55.52-0.23
-0.41%
American Funds New Economy R5